Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets (2014 - 2015)

Ani Pharmaceuticals (ANIP) posted Current Deferred Tax Assets of $8.3 million for Q3 2015, up 3.34% sequentially from $8.0 million in Q2 2015.

Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Ani Pharmaceuticals has reported Current Deferred Tax Assets for 2 years, with the latest figure at $8.3 million in Q3 2015.

Quarterly Current Deferred Tax Assets changed N/A year-over-year to $8.3 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $8.3 million (changed N/A YoY) and the FY2014 annual result came in at $7.6 million, changed N/A from the prior year.
Current Deferred Tax Assets climbed to $8.3 million in Q3 2015 per ANIP's latest filing, from $8.0 million in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $8.3 million in Q3 2015 and troughed at $7.6 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-
10	Ani Pharmaceuticals	1.63 Bn	1.27 Bn	165.89 Mn

Download Data